Aptiv Solutions Appoints Key Executives

Aptiv Solutions has appointed key internal executives to global management roles.
Dr. Phil Birch has been named to the newly created position of senior vice president and corporate brand manager for Adaptive Clinical Trials. Dr. Birch will work with the Aptiv Solutions Innovation Center, Business Development, and Operational teams to ensure strategic growth within the adaptive clinical trials sector. His responsibilities include brand development, market education, developing strategic partnerships and heightening of customer focus across Aptiv Solutions business units.

Dr. Birch previously served as senior vice president of Global Regulatory. He has experience in R&D, strategic marketing and corporate development having held senior management positions in the pharma, biopharma and service industries.

Carolyn Belcher succeeds Dr. Birch as senior director and global head of the Aptiv Solutions Regulatory Business Unit. Ms. Belcher will oversee the worldwide regulatory team, which provides first class regulatory support for clinical development programs and market approval.

Ms. Belcher recently joined the company through the acquisition of SRA Global Clinical Development (GCD), where she was senior director and global head of regulatory affairs and strategic drug development services. Ms. Belcher has more than 17 years of experience within the pharmaceutical and healthcare industry. During her tenure at SRA GCD, she led the regulatory affairs team, which managed projects and assignments from early phase development through to post marketing activities.  

“Our organization is committed to developing customized adaptive clinical trial services for our clients,” said Pat Donnelly, chairman and chief executive officer of Aptiv Solutions. “This past year, we have seen a dramatic increase in sponsor interest in pursuing adaptive design clinical trials and as an organization we are aligning strong leadership and expertise to focus internal resources to help our clients develop, design and execute best-in-class adaptive clinical programs.”